Audiological profile of a patient with MPS type IVA

Saransh Jain, Vikas Mysore Dwarakanath, Suman Suresh


Mucopolysaccharidosis IVA is a rare metabolic disorder caused by the deficiency of N-acetylgalatosamine-6-sulfate-sulfatase, which is helpful in the degradation of keratan sulfate. Hearing loss is common in these individuals, which may be conductive, mixed or sensorineural. The disorder has a manifestation mainly in the skeletal and visceral organs; however, the presence of subtle neurological abnormalities has also been reported. Thus, a detailed audiological evaluation for differentiating sensory pathology with the neural pathology is warranted. The present case highlights the audiological characteristics of a 14 year old male child diagnosed with MPS IVA. Immitance audiometry, Pure tone audiometry, Speech audiometry, Otoacoustic emission and Auditory brainstem responses (ABR) (for threshold estimation) indicated mild sensorineural hearing loss in right ear and moderate mixed hearing loss in the left ear. However, lack of replicability in the ABR waveforms, and difference in the absolute latency for ABR peaks with different rate of stimulus presentation (11.1/sec and 90.1/sec) signifies the presence of retrocochlear pathology. The findings were further strengthened by the absence of speech ABR and the presence of late latency responses. The findings have a direct implication on the audiological rehabilitation of such individuals and the prescription of hearing aid should be made with caution.


mucopolysaccharidosis, mucopolysaccharidosis type IVA, Morquio’s disease, keretan sulfate, glycosaminoglycans, retrocochlear pathology

Full Text:



Parashari, U., Khanduri, S., Bhadury, S., and Rawat, S. Roentgenographic diagnosis of mucopolysaccharidosis with particular reference to Morquio syndrome. South African Journal of Radiology. 2012;16:32-34.

Rekka, P., Rathna, P. V., Jagadeesh, S., and Seshadri, S. Mucopolysaccharidoses type IV A (Morquio syndrome): A case series of three siblings. Journal of the Indian Society of Pedontics and preventive Dentistry. 2012;30:66-69.

Nelson J. Incidence of the mucopolysaccharidoses in Northern Ireland. Human Genetics. 1997;101(3):355-8.

Nelson J, Crowhurst J, Carey B, Greed L. Incidence of the mucopolysaccharidoses in Western Australia. American Journal of Medical Genetics Part A. 2003;123A(3):310-3.

Kagalwala, T. Y., Bharucha, B. A., Kumta, N. B., and Naik, G. G. The mucopolysaccharidoses: A study of 48 cases. Indian Journal of Pediatrics. 1988;55(6):919-25.

Bettelheim, F. A., and Plessy, B. (1975). The hydration of proteoglycans of bovine cornea. Biochemics et Biophysica Acta. 1975;381:203-214.

Akhtar S, Bron AJ, Hayes AJ, Meek KM, Caterson B. Role of keratan sulphate (sulphated poly -N-acetyllactosamine repeats) in keratoconic cornea, histochemical, and ultrastructural analysis. Graefes Archive for Clinical and Experimental Ophthalmology. 2011;249(3):413-20.

Wakitani S, Okabe T, Horibe S, Mitsuoka T, Saito M, Koyama T, et al. Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months. Journal of Tissue Engineering and Regenerative Medicine. 2011;5(2):146-50.

Kasmann-Kellner B, Weindler J, Pfau B, Ruprecht KW. Ocular changes in mucopolysaccharidosis IV A (Morquio A syndrome) and long-term results of perforating keratoplasty. Ophthalmologica. 1999;213(3):200-205.

Ebara S, Kinoshita T, Yuzawa Y, Takahashi J, Nakamura I, Hirabayashi H, et al. A case of mucopolysaccharidosis IV with lower leg paresis due to thoraco-lumbar kyphoscoliosis. Journal of Clinical Neuroscience. 2003;10(3):358-61.

Rolling I, Clausen N, Nyvad B, Sindet-Pedersen S. Dental findings in three siblings with Morquio's syndrome. International Journal of Paediatric Dentistry. 1999;9(3):219-24.

Bredenkamp JK, Smith ME, Dudley JP, Williams JC, Crumley RL, Crockett DM. OTOLARYNGOLOGIC MANIFESTATIONS OF THE MUCOPOLYSACCHARIDOSES. Annals of Otology Rhinology and Laryngology. 1992;101(6):472-8.

Riedner ED, Levin LS. Hearing patterns in Morquio's syndrome (mucopolysaccharidosis IV). Archives of otolaryngology (Chicago, Ill : 1960). 1977;103(9):518-20.

Schleier E, Streubel HG. Phoniatric aspects of children with mucopolysaccharidosis. Folia phoniatrica. 1976;28(2):65-72.

Barranger, J. A., and Cabrera-Salazar, M. A. Lysosomal storage disorders. Plenum, New York. 2002

Paparella, M. M., Oda, M., Hirade, F. et al. Pathology of SNHL in otitis media. Annals of Otology Rhinology and Laryngology. 1972; 93:623-629.

Leroy, J. G., and Crocker, A. C. Clinical definition of Hunter-Hurler phenotypes. A review of 50 patients. American Journal of Diseases of Children. 1966;112:518–530.

Thalmann I, Shibasaki O, Comegys TH, Henzl MT, Senarita M, Thalmann R. DETECTION OF A BETA-PARVALBUMIN ISOFORM IN THE MAMMALIAN INNER-EAR. Biochemical and Biophysical Research Communications. 1995;215(1):142-7.

Davison JE, Kearney S, Horton J, Foster K, Peet AC, Hendriksz CJ. Intellectual and neurological functioning in Morquio syndrome (MPS IVa). Journal of Inherited Metabolic Disease. 2013;36(2):323-8.

Gorlin, R. J., Cohen, M. M., Hennekam, R. C. M. Syndromes of the Head and Neck. New York: Oxford University Press. 2001